PL327141A1 - Method of obtaining 9,11 beta-epoxysteroides - Google Patents

Method of obtaining 9,11 beta-epoxysteroides

Info

Publication number
PL327141A1
PL327141A1 PL96327141A PL32714196A PL327141A1 PL 327141 A1 PL327141 A1 PL 327141A1 PL 96327141 A PL96327141 A PL 96327141A PL 32714196 A PL32714196 A PL 32714196A PL 327141 A1 PL327141 A1 PL 327141A1
Authority
PL
Poland
Prior art keywords
epoxysteroides
beta
obtaining
Prior art date
Application number
PL96327141A
Other languages
English (en)
Inventor
Xiaoyong Fu
Tiruvettipuram K Thiruvengadam
Chou-Hong Tann
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL327141A1 publication Critical patent/PL327141A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
PL96327141A 1995-12-20 1996-12-18 Method of obtaining 9,11 beta-epoxysteroides PL327141A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57556295A 1995-12-20 1995-12-20

Publications (1)

Publication Number Publication Date
PL327141A1 true PL327141A1 (en) 1998-11-23

Family

ID=24300812

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96327141A PL327141A1 (en) 1995-12-20 1996-12-18 Method of obtaining 9,11 beta-epoxysteroides

Country Status (12)

Country Link
EP (1) EP0873352A1 (xx)
JP (1) JP2000502102A (xx)
KR (1) KR20000064495A (xx)
CN (1) CN1209138A (xx)
AU (1) AU1331097A (xx)
BR (1) BR9612064A (xx)
CZ (1) CZ191398A3 (xx)
IL (1) IL125004A0 (xx)
MX (1) MX9804957A (xx)
NO (1) NO982877L (xx)
PL (1) PL327141A1 (xx)
WO (1) WO1997022616A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE046243T2 (hu) 2008-05-28 2020-02-28 Reveragen Biopharma Inc Nem-hormonális NF-KB szteroid modulátorok betegség kezelésére
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN103588853A (zh) * 2013-11-28 2014-02-19 浙江省天台县奥锐特药业有限公司 制备9,11β-环氧甾族化合物的方法
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
CN107266519B (zh) * 2016-04-08 2021-06-29 天津金耀集团有限公司 一种9β，11β-环氧-17α-羟基-16α-甲基-21-氯代-1，4孕甾二烯-3，20-二酮新晶型及其制备方法
CN109180767A (zh) * 2018-09-04 2019-01-11 浙江仙琚制药股份有限公司 一种制备糠酸莫米松的方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1145170B (de) * 1959-03-13 1963-03-14 Scherico Ltd Verfahren zur Herstellung von 9,11-Oxidosteroiden der Androstan- und Pregnanreihe
GB1244604A (en) * 1967-08-25 1971-09-02 Organon Labor Ltd Substituted methylene steroids and their preparation
GB1416427A (en) * 1972-01-12 1975-12-03 Akzo Nv Alkylated pregnanes and process for obtaining same
DE2617655C2 (de) * 1976-04-21 1984-11-08 F. Hoffmann-La Roche & Co Ag, Basel Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE3064460D1 (en) * 1979-01-24 1983-09-08 Akzo Nv Novel alkylated pregnanes, processes for their preparation and pharmaceutical compositions containing same
DD268954A1 (de) * 1983-04-22 1989-06-14 Jenapharm Veb Verfahren zur herstellung von 9alpha-halogen-11beta-formyloxysteroiden der pregnanreihe
FR2675146A1 (fr) * 1991-04-10 1992-10-16 Roussel Uclaf Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.

Also Published As

Publication number Publication date
AU1331097A (en) 1997-07-14
BR9612064A (pt) 1999-02-23
CN1209138A (zh) 1999-02-24
NO982877D0 (no) 1998-06-19
NO982877L (no) 1998-08-20
WO1997022616A1 (en) 1997-06-26
MX9804957A (es) 1998-09-30
EP0873352A1 (en) 1998-10-28
JP2000502102A (ja) 2000-02-22
CZ191398A3 (cs) 1998-11-11
KR20000064495A (ko) 2000-11-06
IL125004A0 (en) 1999-01-26

Similar Documents

Publication Publication Date Title
PL330753A1 (en) Method of obtaining 2,3-dihalogenopropanols
PL326367A1 (en) Method of obtaining 1,1,1,3,3-pentafluoropropane
PL323236A1 (en) Method of obtaining lerkanipidin chlorchydride
PL322279A1 (en) Method of obtaining 1,2-benzoylthiazolin-3-ones
HUP9900360A3 (en) Method of preparing norbenzomorphane-derivatives
PL327147A1 (en) Method of obtaining dihydropyrimidinones
GB2308522B (en) Redialling method
PL327141A1 (en) Method of obtaining 9,11 beta-epoxysteroides
GB9502225D0 (en) Method
PL326978A1 (en) Method of obtaining dioxyaza bicyclohexanes
GB9510727D0 (en) Method
PL297518A1 (en) Method of obtaining 4,6-dialkoxypyrimidines
GB9525481D0 (en) Novel method
GB9507230D0 (en) Novel method
PL312826A1 (en) Method of obtaining dilthiazeme
PL323605A1 (en) Method of obtaining substituted 5-hydroxy-oxazolydin-4-ones
PL315675A1 (en) Derivatives of 12, 13-epoxytholosine and method of obtaining them
GB9511828D0 (en) Method
PL336664A1 (en) Method of obtaining 1,1,1,3,3- pentachlorobutane
PL306977A1 (en) Method of obtaining 1,8-diacetoxy-3-carboxyantraquinone
PL303736A1 (en) Method of obtaining 2,4,6-trichloroaminobenzene
PL303603A1 (en) Method of obtaining 2,6-dimethyl-o-benzoquinone
PL308968A1 (en) Method of obtaining 12beta, 15alpha-dihydroxy-4-androsten-3-one
PL308967A1 (en) Method of obtaining 15alpha,17beta-dihydroxy-17alpha- methylo-4-androsten-3-one
PL311598A1 (en) Method of obtaining 1,4-naphtoquinone